Enovis Return on Tangible Equity 2010-2025 | ENOV

Current and historical return on tangible equity values for Enovis (ENOV) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Enovis Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-03-31 $-0.81B $-0.46B 179.40%
2024-12-31 $-0.83B $-0.45B 177.63%
2024-09-30 $-0.12B $-0.46B 40.61%
2024-06-30 $-0.09B $-0.45B 88.56%
2024-03-31 $-0.08B $-0.51B -96.47%
2023-12-31 $-0.03B $0.23B -10.75%
2023-09-30 $-0.08B $0.31B -22.21%
2023-06-30 $-0.14B $0.31B -40.61%
2023-03-31 $-0.05B $0.38B -13.73%
2022-12-31 $-0.01B $0.36B -7.94%
2022-09-30 $0.02B $0.33B 4.78%
2022-06-30 $0.12B $0.45B 46.54%
2022-03-31 $0.07B $-0.43B -151.11%
2021-12-31 $0.07B $1.57B -65.60%
2021-09-30 $0.11B $-0.59B -12.58%
2021-06-30 $0.09B $-0.73B -8.89%
2021-03-31 $0.06B $-0.69B -4.59%
2020-12-31 $0.04B $-1.39B -2.91%
2020-09-30 $-0.01B $-1.42B 0.55%
2020-06-30 $-0.01B $-1.47B 0.70%
2020-03-31 $-0.47B $-1.50B 28.06%
2019-12-31 $-0.53B $-1.43B 25.73%
2019-09-30 $-0.47B $-1.91B 34.29%
2019-06-30 $-0.44B $-1.88B 50.77%
2019-03-31 $0.06B $-2.98B -16.30%
2018-12-31 $0.14B $1.35B 33.96%
2018-09-30 $0.11B $0.01B 91.06%
2018-06-30 $0.12B $0.07B 96.06%
2018-03-31 $0.14B $0.21B 318.60%
2017-12-31 $0.15B $0.17B -173.56%
2017-09-30 $0.18B $0.05B -101.44%
2017-06-30 $0.16B $-0.26B -55.00%
2017-03-31 $0.15B $-0.31B -42.90%
2016-12-31 $0.13B $-0.17B -32.93%
2016-09-30 $0.14B $-0.40B -27.69%
2016-06-30 $0.13B $-0.47B -23.56%
2016-03-31 $0.14B $-0.52B -26.67%
2015-12-31 $0.17B $-0.56B -32.67%
2015-09-30 $0.20B $-0.58B -39.57%
2015-06-30 $0.26B $-0.42B -51.78%
2015-03-31 $0.40B $-0.50B -73.65%
2014-12-31 $0.37B $-0.56B -100.82%
2014-09-30 $0.33B $-0.52B -92.53%
2014-06-30 $0.30B $-0.58B -105.78%
2014-03-31 $0.16B $0.19B -76.17%
2013-12-31 $0.16B $-0.50B -36.94%
2013-09-30 $0.14B $-0.25B -28.57%
2013-06-30 $0.09B $-0.29B -16.94%
2013-03-31 $0.05B $-0.66B -7.78%
2012-12-31 $-0.08B $-0.72B 15.66%
2012-09-30 $-0.11B $-0.50B 31.34%
2012-06-30 $-0.11B $-0.48B 48.93%
2012-03-31 $-0.11B $-0.42B 105.97%
2011-12-31 $0.01B $-0.06B 166.67%
2011-09-30 $0.03B $0.03B 141.18%
2011-06-30 $0.03B $0.03B 160.00%
2011-03-31 $0.02B $0.01B 143.28%
2010-12-31 $0.02B $0.02B 93.15%
2010-09-30 $0.02B $0.02B 61.22%
2010-06-30 $0.02B $0.02B 65.93%
2010-03-31 $0.02B $0.02B 83.95%
2009-12-31 $0.02B $0.04B 168.42%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.944B $2.108B
Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.084B 57.36
Doximity (DOCS) United States $11.307B 52.35
Hims & Hers Health (HIMS) United States $10.719B 111.37
Tempus AI (TEM) United States $9.847B 0.00
IRhythm Technologies (IRTC) United States $4.340B 0.00
Inspire Medical Systems (INSP) United States $3.842B 60.03
Hinge Health (HNGE) United States $3.717B 0.00
Privia Health (PRVA) United States $2.496B 170.58
Phreesia (PHR) United States $1.590B 0.00
10x Genomics (TXG) United States $1.576B 0.00
Schrodinger (SDGR) United States $1.542B 0.00
Azenta (AZTA) United States $1.532B 71.21
Clover Health Investments (CLOV) United States $1.486B 0.00
Omnicell (OMCL) United States $1.344B 23.71
Evolent Health (EVH) United States $1.313B 111.80
Claritev (CTEV) United States $0.761B 0.00
Fulgent Genetics (FLGT) United States $0.587B 0.00
Veradigm (MDRX) United States $0.547B 0.00
Standard BioTools (LAB) United States $0.501B 0.00
Butterfly Network (BFLY) United States $0.448B 0.00
Talkspace (TALK) United States $0.442B 132.00
Outset Medical (OM) United States $0.344B 0.00
TruBridge (TBRG) United States $0.331B 735.33
Health Catalyst (HCAT) United States $0.271B 0.00
Nyxoah SA (NYXH) Belgium $0.258B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.233B 0.00
CapsoVision (CV) United States $0.212B 0.00
KORU Medical Systems (KRMD) United States $0.161B 0.00
Zepp Health (ZEPP) Netherlands $0.150B 0.00
American Well (AMWL) United States $0.131B 0.00
EUDA Health Holdings (EUDA) Singapore $0.123B 0.00
Pulmonx (LUNG) United States $0.117B 0.00
MDxHealth SA (MDXH) Belgium $0.103B 0.00
CareCloud (CCLD) United States $0.101B 3.84
Insight Molecular Diagnostics (IMDX) United States $0.082B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.068B 0.00
111 (YI) China $0.065B 0.00
P3 Health Partners (PIII) United States $0.045B 0.00
HeartBeam (BEAT) United States $0.042B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
Precipio (PRPO) United States $0.024B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
MSP Recovery (MSPR) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.005B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00